Financhill
Back

Veradigm 10K Form

Sell
43

MDRX
Veradigm

Last Price:
9.40
Seasonality Move:
12.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive MDRX News And Ratings

See the #1 stock for the next 7 days that we like better than MDRX

MDRX Financial Statistics

Sales & Book Value

Annual Sales: $1.5B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $10.77
Price / Book: 0

Profitability

EPS (TTM): 0.41000
Net Income (TTM): $60.63M
Gross Margin: $619.57M
Return on Equity: 0%
Return on Assets: 0%

Veradigm Earnings Forecast

Key Veradigm Financial Ratios

  • The Gross Profit Margin over the past 23 years for MDRX is 41.22%.
  • The Selling, General & Administrative Expenses for MDRX have been equal to 20.88% of Gross Profit Margin.
  • The Research & Development expenses have been 12.89% of Revenue.
  • The Interest Expense is 9.79% of Operating Income.
  • The Net Earning history of MDRX is 8.94% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 11 years.

Veradigm Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Technology
Sector: Health Care
Current Symbol: MDRX
CUSIP: 01988P
Website: veradigm.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MDRX Technical Analysis vs Fundamental Analysis

Sell
43
Veradigm (MDRX) is a Sell

Is Veradigm a Buy or a Sell?

  • Veradigm stock is rated a Sell
    The current Veradigm [MDRX] share price is $9.26. The Score for MDRX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.